I love reading the news posts in Nature and Science that I receive in the journal’s eAlerts. This past month was most interesting because there were two news posts that I thought were actually a bit contradicting. The first one titled “Spending bills put NIH on track for the biggest raise in 12 years” was published in July of this year and explains how both houses of congress want to increase the National Institutes of Health’s (NIH) annual budget (Kaiser, 2015a). The Presidential branch wants to give the NIH a 1 billion dollar increase while just recently, a Senate panel approved a 2 billion increase. The article also goes onto say that certain programs have been given priority such as the Alzheimer’s research and others like the Agency for Healthcare Research and Quality will receive cuts. Needless to say, I am sure that biomedical and behavioral scientists throughout the country are probably ecstatic. But is this really a good thing?
The other news blurb I read was titled an “A for effort, C for impact from U.S. biomedical research, study concludes” also written by the same author (Kaiser, 2015b). In this article, Jocelyn Kaiser reports the results of a study by two research scientists Dr. Arturo Casadevall and Anthony Bowen who examined publications in the PubMed database and the number of authors, along with the approval of new drugs and their work was published in the journal Proceedings of the National Academy of Sciences (USA). The researchers compared publication outputs with the number of new molecules approved by the U.S. government. What they found was not too surprising.
The Alden March Bioethics Institute offers a Master of Science in Bioethics, a Doctorate of Professional Studies in Bioethics, and Graduate Certificates in Clinical Ethics and Clinical Ethics Consultation. For more information on AMBI's online graduate programs, please visit our website.